CARTESIAN THERAPEUTICS INC (RNAC:NASDAQ)

$6.93 0.48 (7.4419%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 63

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed CARTESIAN THERAPEUTICS INC (RNAC:NASDAQ) News Sources

Generalized Myasthenia Gravis Market on the Brink of Change: 8 Promising Late-Stage Drugs Signal a New Treatment Era | DelveInsight

15-04-2026

yahoo.com

external link

Cartesian Therapeutics, Inc. (RNAC) Soars 10.3%: Is Further Upside Left in the Stock?

20-04-2026

yahoo.com

external link

Cartesian Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

30-04-2026

yahoo.com

external link

Cartesian Therapeutics, Inc. (RNAC) Reports Q1 Loss, Lags Revenue Estimates

30-04-2026

yahoo.com

external link

Cartesian Therapeutics Announces New Employment Inducement Grants

04-05-2026

yahoo.com

external link

Cartesian Therapeutics to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ

12-05-2026

yahoo.com

external link

We're Keeping An Eye On Cartesian Therapeutics' (NASDAQ:RNAC) Cash Burn Rate

17-05-2026

yahoo.com

external link

Myasthenia Gravis Market Set to Surpass USD 16 Billion by 2036, Fueled by Rising Diagnosed Prevalence and Wave of Targeted Biologic Approvals | DelveInsight

18-05-2026

yahoo.com

external link

Emerging Hope in Multiple Myeloma Market: 7 Late-Stage Therapies Nearing the Finish Line | DelveInsight

25-05-2026

yahoo.com

external link

Cartesian Therapeutics Secures up to $150 Million of Non-Dilutive Financing from K2 HealthVentures and Expects Topline Data from the Phase 3 AURORA Trial in First Quarter 2027

26-05-2026

yahoo.com

external link

CARTESIAN THERAPEUTICS INC (RNAC:NASDAQ) Sentiment Trend

0 25 50 75 100 84 58 64 2 61 82 14 90 84 87 15-04-2026 20-04-2026 30-04-2026 04-05-2026 12-05-2026 17-05-2026 18-05-2026 25-05-2026 26-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

CARTESIAN THERAPEUTICS INC (RNAC:NASDAQ) FAQs

toggle

What is the current price of CARTESIAN THERAPEUTICS INC (RNAC:NASDAQ)?

The current price of CARTESIAN THERAPEUTICS INC (RNAC:NASDAQ) is $6.93.


toggle

CARTESIAN THERAPEUTICS INC (RNAC:NASDAQ) absolute price change since previous trading day?

The absolute price change of CARTESIAN THERAPEUTICS INC (RNAC:NASDAQ) since the previous trading day is $0.48.


toggle

CARTESIAN THERAPEUTICS INC (RNAC:NASDAQ) percentage price change since previous trading day?

The percentage price change of CARTESIAN THERAPEUTICS INC (RNAC:NASDAQ) since the previous trading day is 7.4419%.


toggle

What is the most recent average sentiment score for CARTESIAN THERAPEUTICS INC (RNAC:NASDAQ)?

The most recent average sentiment score for CARTESIAN THERAPEUTICS INC (RNAC:NASDAQ) is 63 out of 100.


toggle

What is the most recent average sentiment for CARTESIAN THERAPEUTICS INC (RNAC:NASDAQ)?

The most recent sentiment for CARTESIAN THERAPEUTICS INC (RNAC:NASDAQ) is .


SEC-8K** Filing Available For CARTESIAN THERAPEUTICS INC (RNAC:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Similar Securities People Also Ask

RNAZ (Transcode Therapeutics Inc)
RNA (Avidity Biosciences Inc)
CYCN (Cyclerion Therapeutics Inc)

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.